Last Updated: 23/07/2020

Effectiveness of Intermittent Preventive Treatment With Sulfadoxine-Pyrimethamine During Pregnancy on Maternal and Birth Outcomes in Machinga District, Malawi

Objectives

This cross-sectional delivery survey in Malawi was undertaken as part of a group of studies in 6 countries aimed at assessing the current effectiveness of IPTp-SP.

Principal Institution

Malaria Alert Centre (MAC), Malawi
Centers for Disease Control and Prevention (CDC), United States

Principal Investigators / Focal Persons

Julie Gutman

Partner Institutions

National Malaria Control Programme (NMCP) Malawi
Malawi College of Medicine, Kamuzu University of Health Sciences (KUHeS)

Themes

Drug-based Strategies

Date

Mar 2010 — Aug 2010

Total Project Funding

$40,000

Funding Details
U.S. President’s Malaria Initiative (PMI), United States
Country / Project Site(s)

Malawi

SHARE

Related Resources

Technical consultation to assess evidence on community-based delivery of intermittent preventive treatment in pregnancy for malaria
Technical consultation to assess evidence on community-based delivery of intermittent preventive treatment in pregnancy for malaria
Malaria chemoprevention efficacy study protocol
Malaria chemoprevention efficacy study protocol
Safety of artemisinin and non-artemisinin antimalarials in the first trimester of pregnancy
Safety of artemisinin and non-artemisinin antimalarials in the first trimester of pregnancy

Related Projects

Implementation effectiveness of intermittent preventive treatment of malaria in pregnancy using sulfadoxine-pyrimethamine in the Volta region of Ghana
Sep 2016 —
Dec 2018
Effectiveness of intermittent screening and treatment of malaria in pregnancy (ISTp) on maternal and birth outcomes in selected districts in Rwanda
Dec 2017 —
Dec 2020
Assessing the effectiveness of community delivery of Intermittent preventive treatment in pregnancy (IPTp) in Malawi
SHARE